Today we give a shout-out to ACSH friend Michael D. Shaw for his provocative piece that was posted on the HealthNewsDigest website. This topic is something we have written about regularly: What happens to pharmaceutical research when big companies merge and/or layoff scientists?
Until the past few years, few people had even heard of hepatitis C. Yet, it is estimated that 200 million people worldwide are infected with the hepatitis C virus (HCV) approximately four times that of HIV.
Whatever Happened to AIDS? How the Pharmaceutical Industry Tamed HIV, explains the central role played by the pharmaceutical industry in transforming AIDS from an inevitably fatal illness to a chronic, manageable disease. This story is largely untold.